Group 1 - The core idea of the article highlights the significant achievements of the Sci-Tech Innovation Board (STAR Market) since its establishment, emphasizing its role in supporting "hard technology" enterprises and facilitating the registration-based reform in China's capital market [1][2] - As of July 21, 2025, the STAR Market has 589 listed companies with a total market capitalization of approximately 7.4 trillion yuan, having raised over 1.1 trillion yuan in total through IPOs and refinancing [1] - The STAR Market has become a vital platform for the development of new productive forces, with a focus on strategic emerging industries such as new-generation information technology, biomedicine, and high-end equipment manufacturing, which account for over 80% of the listed companies [2] Group 2 - The compound annual growth rates for revenue and net profit attributable to shareholders of STAR Market companies are 19% and 9%, respectively, since 2019 [2] - Among the 54 unprofitable companies at the time of listing, 22 have achieved profitability post-listing, and 19 out of 20 companies listed under the fifth set of standards have received approval for their self-developed drugs/vaccines [2] - In 2024, STAR Market companies' total R&D investment reached 168 billion yuan, more than three times their net profit, with a median R&D investment-to-revenue ratio of 12.6%, leading all A-share sectors [2]
科创板迎来6周岁生日 上市公司589家 总市值超7万亿元
Shen Zhen Shang Bao·2025-07-21 22:44